Recombinant Human NTMT1 Protein，His

NTMT1 (N-terminal methyltransferase 1) is a methyltransferase enzyme that plays a crucial role in the post-translational modification of proteins by catalyzing the methylation of the N-terminal amino group of certain proteins. This methylation process is essential for various biological functions, including protein stability, localization, and interactions, thereby influencing cellular signaling pathways and metabolic processes. Dysregulation of NTMT1 has been implicated in a variety of diseases, including cancer and neurodegenerative disorders, as altered N-terminal methylation can affect protein function and contribute to disease progression. The recombinant expression of NTMT1 protein has become a focus of research to better understand its enzymatic properties and the mechanisms by which it modifies target proteins. By studying NTMT1 in vitro, researchers aim to elucidate its substrate specificity, kinetic parameters, and interaction with various protein partners. Additionally, the production of NTMT1 as a recombinant protein is critical for developing potential therapeutic strategies targeting its enzymatic activity, which may offer new avenues for treatment in conditions linked to protein methylation abnormalities. Overall, NTMT1 stands out as a significant protein in cellular regulation, and its study provides insights into the broader implications of protein methylation in health and disease.